BFM
CATX icon

Boothbay Fund Management’s Perspective Therapeutics CATX Stock Holding History

Boothbay Fund Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,150
Closed -$99.4K – 1432
2024
Q4 		$99.4K Buy
+31,150
New +$254K ﹤0.01% 1292

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Boothbay Fund Management's CATX Position: Q1 2025 in Review

Boothbay Fund Management sold out of Perspective Therapeutics (CATX) in Q1 2025, closing a stake of 31,150 shares — an estimated $99.4K sold.

Boothbay Fund Management first reported a position in CATX in Q4 2024 and held it in 1 quarter. The position peaked at $99.4K in Q4 2024. 112 funds tracked by Wall St. Rank hold CATX as of Q1 2025.

  • Boothbay Fund Management reported no remaining Perspective Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 31,150 Perspective Therapeutics shares in Q1 2025, an estimated $99.4K.
  • Boothbay Fund Management first reported a position in Perspective Therapeutics in Q4 2024 and held it in 1 quarter.
  • Boothbay Fund Management's Perspective Therapeutics position peaked at $99.4K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.